Basel Medical Group Ltd income statement BMGL
In fiscal 2025, which ended Jun 30, 2025, Basel Medical Group Ltd reported revenue of $8.9 million. It recorded a net loss of $8.4 million. Diluted earnings per share were -$0.45.
USD in millions, except per-share amounts and margins. The percent under a figure is the change from the year before.
| Line |
FY 2025
Jun 30, 2025
|
|---|---|
| Revenue |
9
|
| Pretax income |
-9
|
| Income tax |
-0
|
| Net income |
-8
|
| Basic EPS |
-0.45
|
| Diluted EPS |
-0.45
|
| Weighted average shares, basic |
19
|
| Weighted average shares, diluted |
19
|
| Margins | |
| Pretax margin |
-97.65%
|
| Profit margin |
-93.96%
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. More on our methodology.
New to this? Read How to Read an Income Statement, With a Real Example.
Company profile
- Industry
- Services-Offices & Clinics of Doctors of Medicine (SIC 8011)
- Listed as
- BMGL (Nasdaq)
- Fiscal year ends
- June 30
- Incorporated in
- Virgin Islands, British
- Headquarters
- Singapore, Singapore
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 2004489
Other Services-Offices & Clinics of Doctors of Medicine companies
- Hims & Hers Health, Inc. HIMS
- Teladoc Health, Inc. TDOC
- Starling Oncology, Inc. STLN
- SBC Medical Group Holdings Inc SBC
- Auna S.A. AUNA
- Airsculpt Technologies, Inc. AIRS
- LifeMD, Inc. LFMD
- Westin Acquisition Corp WSTN
All 12 Services-Offices & Clinics of Doctors of Medicine companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.